Tempus AI investors who suffered over $100,000 in losses between August 2024 and May 2025 have until August 12 to file lead plaintiff claims in a U.S. class action.
 |
| Tempus AI stockholders with losses over $100,000 are urged to act before August 12 to join a class action lawsuit tied to a 19% share price drop and fraud allegations. Image: CH |
New Orleans, USA — July 12, 2025:
Tempus AI is facing a securities class action lawsuit in the United States District Court for the Northern District of Illinois, and investors who purchased shares between August 6, 2024 and May 27, 2025 are being urged to act before the August 12, 2025 deadline to seek lead plaintiff status. The legal action follows a sharp drop in the company’s stock price and serious allegations of misleading public disclosures and questionable corporate conduct.
ClaimsFiler, a free shareholder information service, is alerting investors who suffered financial losses exceeding $100,000 during the class period to join the case now to protect their rights. The lawsuit accuses Tempus AI and certain senior executives of violating federal securities laws by concealing key information regarding the company’s operations, financial reporting, and leadership practices.
The controversy erupted on May 28, 2025, when Spruce Point Capital Management published a report exposing alleged mismanagement and inflated claims about Tempus AI’s artificial intelligence capabilities. The report highlighted that CEO Eric Lefkofsky and close associates have a pattern of exiting ventures before long-term investors suffer losses or diminished returns. It also raised questions about the integrity of the company’s financial reporting, the qualifications of certain board members, and potential irregularities involving Tempus’ partnerships with AstraZeneca and Pathos AI. The report further criticized a recent downward revision in Tempus' financial guidance as evidence of serious internal weakness.
In immediate reaction to the revelations, Tempus AI’s stock plunged by $12.67 per share, a 19.23% decline from its closing price of $65.87 on May 27 to $53.20 on May 28. The drop triggered alarm among shareholders and set the stage for legal action.
The case, formally filed under Shouse v. Tempus AI, Inc., et al., aims to hold the company accountable for the alleged failure to disclose material risks to its investors. Those affected are encouraged to take legal consultation and claim assistance from the law firm Kahn Swick & Foti, LLC.
ClaimsFiler specializes in providing investors with access to ongoing class action cases and helps individuals participate in settlements by offering tools to upload portfolio data, track eligibility, and receive updates. As the Tempus AI case progresses, it highlights the growing scrutiny of technology firms operating in the AI and healthcare sectors and the legal risks tied to inflated market narratives.